insulin analogues

Show Summary Details

Quick Reference

A group of synthetic human insulins with specific alterations in their amino-acid sequences designed to modify their rate of absorption from the injection site (subcutaneous tissue). Some are absorbed much more rapidly and have a shorter duration of action than the older insulins; others are absorbed more slowly but at a constant rate, to prevent peaks in the plasma insulin levels associated with hypoglycaemia. These analogues include the short-acting insulin aspart, insulin glulisine, and insulin lispro and the long-acting insulin detemir and insulin glargine.

Subjects: Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.